Versant Capital Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-10
| Closed | -$1.16K | – | 2049 |
|
|
2023
Q3 | $1.16K | Hold |
10
| – | – | ﹤0.01% | 1487 |
|
|
2023
Q2 | $1.03K | Hold |
10
| – | – | ﹤0.01% | 1591 |
|
|
2023
Q1 | $1.09K | Hold |
10
| – | – | ﹤0.01% | 1417 |
|
|
2022
Q4 | $1.14K | Hold |
10
| – | – | ﹤0.01% | 1271 |
|
|
2022
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 1396 |
|
|
2022
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 1416 |
|
|
2022
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 1429 |
|
|
2021
Q4 | $1K | Hold |
10
| – | – | ﹤0.01% | 1408 |
|
|
2021
Q3 | $1K | Hold |
10
| – | – | ﹤0.01% | 1421 |
|
|
2021
Q2 | $1K | Hold |
10
| – | – | ﹤0.01% | 1419 |
|
|
2021
Q1 | $1K | Hold |
10
| – | – | ﹤0.01% | 1495 |
|
|
2020
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 1635 |
|
|
2020
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 1619 |
|
|
2020
Q2 | $0 | Hold |
10
| – | – | ﹤0.01% | 1694 |
|
|
2020
Q1 | $0 | Hold |
10
| – | – | ﹤0.01% | 1877 |
|
|
2019
Q4 | $0 | Hold |
10
| – | – | ﹤0.01% | 1736 |
|
|
2019
Q3 | $0 | Hold |
10
| – | – | ﹤0.01% | 1746 |
|
|
2019
Q2 | $0 | Sell |
10
-51
| -84% | – | ﹤0.01% | 1877 |
|
|
2019
Q1 | $1K | Hold |
61
| – | – | ﹤0.01% | 1529 |
|
|
2018
Q4 | $1K | Hold |
61
| – | – | ﹤0.01% | 1441 |
|
|
2018
Q3 | $1K | Hold |
61
| – | – | ﹤0.01% | 1486 |
|
|
2018
Q2 | $1K | Sell |
61
-2
| -3% | -$33 | ﹤0.01% | 1475 |
|
|
2018
Q1 | $0 | Buy |
63
+18
| +40% | – | ﹤0.01% | 1746 |
|
|
2017
Q4 | $0 | Hold |
45
| – | – | ﹤0.01% | 1712 |
|
|
2017
Q3 | $0 | Buy |
+45
| New | – | ﹤0.01% | 1646 |
|
|
2017
Q2 | – | Sell |
-45
| Closed | – | – | 1614 |
|
|
2017
Q1 | $0 | Buy |
+45
| New | – | ﹤0.01% | 1609 |
|